{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "520",
                "539"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wrodzon\u0105 wad\u0105 serca"
        },
        {},
        {
            "identifier": "T2",
            "position": [
                "340",
                "353"
            ],
            "subtype": "Negation",
            "type": "T",
            "value": "Nie stosowano"
        },
        {
            "identifier": "T3",
            "position": [
                "354",
                "380"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "leczenia farmakologicznego"
        },
        {
            "icd": "ICD10:Q20",
            "identifier": "N1",
            "referenced": "T1",
            "subtype": "Reference",
            "type": "N",
            "value": "Wrodzone wady rozwojowe jam i po\u00c5\u0082\u00c4\u0085cze\u00c5\u0084 sercowych"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 4 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nNie stosowano leczenia farmakologicznego.\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziewczynka z wrodzon\u0105 wad\u0105 serca przyj\u0119ta do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan do\u015b\u0107 dobry\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia\n    WBC:6.12[10\\\\^3/ul]\n    RBC:4.45[10\\\\^6/ul]\n    HGB:13.4[g/dl]\n    HCT:36.7[%]\n    MCV:82.5[fl]\n    MCH:30.1[pg]\n    MCHC:36.5[g/dl]\n    PLT:282.0[10\\\\^3/ul]\n    RDW-SD:35.9[fl]\n    RDW-CV:11.9[%]\n    PDW:9.0[fl]\n    MPV:8.9[fl]\n    P-LCR:14.7[%]\n    PCT:0.3[%]\n    NEUTR#:1.41[10\\\\^3/ul]\n    NEUTR%:23.1[%]\n    LYMPH#:3.02[10\\\\^3/ul]\n    LYMPH%:49.3[%]\n    MONO#:0.47[10\\\\^3/ul]\n    MONO%:7.70[%]\n    EO#:1.09[10\\\\^3/ul]\n    EO%:17.80[%]\n    BASO#:0.13[10\\\\^3/ul]\n    BASO%:2.10[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nBadanie - Elementy  moczu niewirowanego\n    Leum:11 /uL[ul]\n    Bakm:pojedyncze[wpw]\n    NabP\u0142m:pojedyncze[wpw]\n    Pas\u015al:nieliczny[wpw]\nABL Parametry krytyczne\n    pH:7.360\n    pCO2:42.4[mmHg]\n    BE:-1.60[mmol/L]\n    HCO3:23.3[mmol/L]\n    pO2:45.1[mmHg]\n    O2Sat:77.6[%]\n    Na - ABL:140[mmol/L]\n    K - ABL:4.6[mmol/L]\n    Cl - ABL:105[mmol/L]\n    Ca zj ABL:1.39[mmol/L]\n    Ht - ABL:41.6[%]\n    Hb ABL:13.5[g/dl]\n    FO2Hb:76.4[%]\n    FCOHb:0.8[%]\n    FMetHb:0.7[%]\n    FHbF - ABL:*[%]\n    GLU-ABL:91[mg/dl]\n    mleczany:19[mg/dl]\n    COMMENT_HL7:\nBadanie og\u00f3lne moczu\n    Barwa:\u017c\u00f3\u0142ta\n    Przej:zupe\u0142na\n    SG:1.010\n    pH:6.5\n    LEU:nieobecne[ul]\n    NIT:nieobecne[ul]\n    mKET:nieobecne[mg/dl]\n    mURO:niewzmo\u017cona\n    BIL:nieobecna\n    ERY:nieobecna[ul]\n    GLU-mocz:nieobecna[mg/dl]\n    UPROT:nieobecne[mg/dl]\nImmununochemia -Immulite: COMMENT_HL7:\nD-dimery t. ilo\u015bciowy: D-dimer:76.0[ng/ml]\nFibrynogen (F): FIB:1.81[g/L]\nAntytrombina III (ATIII): ATIII:112.0[%]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:55.7[s]\nINR: INR:1.3\nCzas protrombinowy (PT): PT:13.8[s]\nCzas trombinowy (TT): TT:17.9[s]\nBilirubina ca\u0142kowita TBIL: TBIL:0.70[mg/dl]\nWska\u017anik PT: PT%:80[%]\nBia\u0142ko ca\u0142kowite: TP:7.00[g/dl]\nKreatynina: CREA:0.40[mg/dl]\nMocznik: UREA:19.00[mg/dl]\nASPAT: AST:34.00[IU/L]\nALAT: ALT:35.00[IU/L]\nPLT z morfologii: PLT:282.0[10\\\\^3/ul]\nNT- proBNP: NTpBNP:137.00[pg/ml]\nCK-MB aktywno\u015b\u0107: CK-MBakt.:10.00[IU/L]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:108.4[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:105[cm]\neGFR (1-18r\u017c K) stand.wg.Schwartza  wsp. 0.550: eGFR 1-18K:144.4[ml/min/1,73m2]\n------------------------------------------------\nICD10\n------------------------------------------------\nQ22.1\nQ20.5\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\n------------------------------------------------"
}